Cargando…
Letter to the editor regarding Gholamzad et al., “A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future”
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989607/ https://www.ncbi.nlm.nih.gov/pubmed/31927617 http://dx.doi.org/10.1007/s00011-019-01310-3 |
_version_ | 1783492437989130240 |
---|---|
author | Faissner, Simon |
author_facet | Faissner, Simon |
author_sort | Faissner, Simon |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6989607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-69896072020-02-11 Letter to the editor regarding Gholamzad et al., “A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future” Faissner, Simon Inflamm Res Letter to the Editor Springer International Publishing 2020-01-11 2020 /pmc/articles/PMC6989607/ /pubmed/31927617 http://dx.doi.org/10.1007/s00011-019-01310-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter to the Editor Faissner, Simon Letter to the editor regarding Gholamzad et al., “A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future” |
title | Letter to the editor regarding Gholamzad et al., “A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future” |
title_full | Letter to the editor regarding Gholamzad et al., “A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future” |
title_fullStr | Letter to the editor regarding Gholamzad et al., “A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future” |
title_full_unstemmed | Letter to the editor regarding Gholamzad et al., “A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future” |
title_short | Letter to the editor regarding Gholamzad et al., “A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future” |
title_sort | letter to the editor regarding gholamzad et al., “a comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989607/ https://www.ncbi.nlm.nih.gov/pubmed/31927617 http://dx.doi.org/10.1007/s00011-019-01310-3 |
work_keys_str_mv | AT faissnersimon lettertotheeditorregardinggholamzadetalacomprehensivereviewonthetreatmentapproachesofmultiplesclerosiscurrentlyandinthefuture |